Krystal Biotech
KRYS
KRYS
113 hedge funds and large institutions have $851M invested in Krystal Biotech in 2021 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 45 increasing their positions, 34 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.5% less ownership
Funds ownership: 73.85% → 73.36% (-0.5%)
24% less capital invested
Capital invested by funds: $1.11B → $851M (-$264M)
Holders
113
Holding in Top 10
1
Calls
$35.8M
Puts
$22.3M
Top Buyers
| 1 | +$10.1M | |
| 2 | +$7.02M | |
| 3 | +$5.58M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$3.79M |
| 5 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$3.03M |
Top Sellers
| 1 | -$12M | |
| 2 | -$9.74M | |
| 3 | -$7.59M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$6.5M |
| 5 |
Goldman Sachs
New York
|
-$5.98M |